CS logo
small CS logo
Johns Hopkins Investigational Drug Service

Baltimore, Maryland, United States

About Johns Hopkins Investigational Drug Service


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Johns Hopkins Investigational Drug Service


During the past decade, Johns Hopkins Investigational Drug Service conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment

Rows per page:

0–0 of 0

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Johns Hopkins Investigational Drug Service


According to Clinical.Site data, the most researched conditions in "Johns Hopkins Investigational Drug Service" are "Duchenne Muscular Dystrophy" (2 trials), "Anaplastic Astrocytoma" (1 trials), "Anaplastic Ganglioglioma" (1 trials), "Anaplastic Oligodendroglioma" (1 trials) and "Anaplastic Pleomorphic Xanthoastrocytoma" (1 trials). Many other conditions were trialed in "Johns Hopkins Investigational Drug Service" in a lesser frequency.

Clinical Trials Intervention Types at Johns Hopkins Investigational Drug Service


Most popular intervention types in "Johns Hopkins Investigational Drug Service" are "Biological" (3 trials) and "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "PF-06252616" (2 trials), "Antibody Drug Conjugate Chemotherapeutic" (1 trials), "Placebo" (1 trials), "dabrafenib" (1 trials) and "trametinib" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Johns Hopkins Investigational Drug Service


The vast majority of trials in "Johns Hopkins Investigational Drug Service" are 2 trials for "All" genders and 2 trials for "Male" genders.

Clinical Trials Status at Johns Hopkins Investigational Drug Service


Currently, there are NaN active trials in "Johns Hopkins Investigational Drug Service". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Johns Hopkins Investigational Drug Service, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Johns Hopkins Investigational Drug Service, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status